Maxillary Sinus Augmentation using TGF-β and Bone Grafting in Dogs

歐 嘉得(Chia-Teh Ou), 董 醒任(Shing-Zeng Dung), 吳 忠憲(Chung-Hsien Wu), 柯 文昌(Wen-Chang Ko), 李 勝揚(Sheng-Yang Lee)

Research output: Contribution to journalArticle

Abstract

Dental implants may maintain residual alveolar ridge, avoid preparation of the healthy tooth, and provide better retention, support, and chewing functions. However, in the maxillary posterior areas the size and extension of the sinus cavities often jeopardized implantation of dental implants. The mechanisms involved in sinus augmentation and osseointegration are still not fully understood. The amount of new bone regenerated may not be adequate and the time for bone healing may take years to complete; therefore, the success rate of osseointegration in augmented sinus may be lower. Two critical processes for the enhancement of bone healing are to increase the number of local osteoprogenitor cells and to accelerate the rate of bone remodeling. TGF-β may directly or indirectly regulate cells of the bone marrow and re-establish the osteoblast phenotype and enhance new bone formation. During skeletal remodeling, bone grafting materials may also be used to induce or conduct new bone formation. The purpose of this investigation was to evaluate the potential use of TGF-β and / or bone grafting materials on sinus augmentation in vivo. Two, four and six months after sinus elevation and TGF-β and bone graft implantation, dogs were sacrificed. Results were assessed using clinical, histologic, and radiograghic techniques. SEM examination was also performed to evaluate the level of osseointegration ultrastructurally. Computed tomography (CT) showed an increase in mineralization over time for all study groups. CT showed that sinuses grafted with TGE-β /OsteoGen or autogenous bone/OsteoGen exhibited greater bone density than sites grafted with OsteoGen only. Histological results of the present study indicated that TGF-β/OsteoGen, autogenous bone/OsteoGen, and OsteoGen promoted similar amount of new blood vessels and new bone in grafted maxillary sinus. It appeared that TGF-β/OsteoGen formed more new bone marrow. New bone was formed primarily around OsteoGen. While OsteoGen was resorbed, there were still tremendous amounts of residual OsteoGen particles after 6 months of grafting. More new bone marrows were formed as graft time increased.
Original languageEnglish
Pages (from-to)79-92
Number of pages14
Journal中華民國口腔顎面外科學會雜誌
Volume10
Issue number2
Publication statusPublished - 1999

Fingerprint

Bone Transplantation
Maxillary Sinus
Durapatite
Dogs
Bone and Bones
Osseointegration
Dental Implants
Osteogenesis
Bone Marrow
Tomography
Tooth Preparation
Transplants
Histological Techniques
Alveolar Process
Bone Remodeling
Mastication
Osteoblasts
Bone Marrow Cells
Bone Density
Blood Vessels

Keywords

  • TGF-β
  • sinus augmentation
  • bone grafting material
  • osteoinduction
  • osteoconduction.

Cite this

歐嘉得(Chia-Teh O, 董醒任(Shing-Zeng D, 吳忠憲(Chung-Hsien W, 柯文昌(Wen-Chang K, & 李勝揚(Sheng-Yang L (1999). Maxillary Sinus Augmentation using TGF-β and Bone Grafting in Dogs. 中華民國口腔顎面外科學會雜誌, 10(2), 79-92.

Maxillary Sinus Augmentation using TGF-β and Bone Grafting in Dogs. / 歐嘉得(Chia-Teh Ou); 董醒任(Shing-Zeng Dung); 吳忠憲(Chung-Hsien Wu); 柯文昌(Wen-Chang Ko); 李勝揚(Sheng-Yang Lee).

In: 中華民國口腔顎面外科學會雜誌, Vol. 10, No. 2, 1999, p. 79-92.

Research output: Contribution to journalArticle

歐嘉得(Chia-TehO, 董醒任(Shing-ZengD, 吳忠憲(Chung-HsienW, 柯文昌(Wen-ChangK & 李勝揚(Sheng-YangL 1999, 'Maxillary Sinus Augmentation using TGF-β and Bone Grafting in Dogs', 中華民國口腔顎面外科學會雜誌, vol. 10, no. 2, pp. 79-92.
歐嘉得(Chia-TehO, 董醒任(Shing-ZengD, 吳忠憲(Chung-HsienW, 柯文昌(Wen-ChangK, 李勝揚(Sheng-YangL. Maxillary Sinus Augmentation using TGF-β and Bone Grafting in Dogs. 中華民國口腔顎面外科學會雜誌. 1999;10(2):79-92.
歐嘉得(Chia-Teh Ou) ; 董醒任(Shing-Zeng Dung) ; 吳忠憲(Chung-Hsien Wu) ; 柯文昌(Wen-Chang Ko) ; 李勝揚(Sheng-Yang Lee). / Maxillary Sinus Augmentation using TGF-β and Bone Grafting in Dogs. In: 中華民國口腔顎面外科學會雜誌. 1999 ; Vol. 10, No. 2. pp. 79-92.
@article{a26bf8d8b82b4d188b9678fee9541e4e,
title = "Maxillary Sinus Augmentation using TGF-β and Bone Grafting in Dogs",
abstract = "Dental implants may maintain residual alveolar ridge, avoid preparation of the healthy tooth, and provide better retention, support, and chewing functions. However, in the maxillary posterior areas the size and extension of the sinus cavities often jeopardized implantation of dental implants. The mechanisms involved in sinus augmentation and osseointegration are still not fully understood. The amount of new bone regenerated may not be adequate and the time for bone healing may take years to complete; therefore, the success rate of osseointegration in augmented sinus may be lower. Two critical processes for the enhancement of bone healing are to increase the number of local osteoprogenitor cells and to accelerate the rate of bone remodeling. TGF-β may directly or indirectly regulate cells of the bone marrow and re-establish the osteoblast phenotype and enhance new bone formation. During skeletal remodeling, bone grafting materials may also be used to induce or conduct new bone formation. The purpose of this investigation was to evaluate the potential use of TGF-β and / or bone grafting materials on sinus augmentation in vivo. Two, four and six months after sinus elevation and TGF-β and bone graft implantation, dogs were sacrificed. Results were assessed using clinical, histologic, and radiograghic techniques. SEM examination was also performed to evaluate the level of osseointegration ultrastructurally. Computed tomography (CT) showed an increase in mineralization over time for all study groups. CT showed that sinuses grafted with TGE-β /OsteoGen or autogenous bone/OsteoGen exhibited greater bone density than sites grafted with OsteoGen only. Histological results of the present study indicated that TGF-β/OsteoGen, autogenous bone/OsteoGen, and OsteoGen promoted similar amount of new blood vessels and new bone in grafted maxillary sinus. It appeared that TGF-β/OsteoGen formed more new bone marrow. New bone was formed primarily around OsteoGen. While OsteoGen was resorbed, there were still tremendous amounts of residual OsteoGen particles after 6 months of grafting. More new bone marrows were formed as graft time increased.",
keywords = "TGF-β, sinus augmentation, bone grafting material, osteoinduction, osteoconduction.",
author = "歐, {嘉得(Chia-Teh Ou)} and 董, {醒任(Shing-Zeng Dung)} and 吳, {忠憲(Chung-Hsien Wu)} and 柯, {文昌(Wen-Chang Ko)} and 李, {勝揚(Sheng-Yang Lee)}",
year = "1999",
language = "English",
volume = "10",
pages = "79--92",
journal = "中華民國口腔顎面外科學會雜誌",
publisher = "中華民國口腔顎面外科學會",
number = "2",

}

TY - JOUR

T1 - Maxillary Sinus Augmentation using TGF-β and Bone Grafting in Dogs

AU - 歐, 嘉得(Chia-Teh Ou)

AU - 董, 醒任(Shing-Zeng Dung)

AU - 吳, 忠憲(Chung-Hsien Wu)

AU - 柯, 文昌(Wen-Chang Ko)

AU - 李, 勝揚(Sheng-Yang Lee)

PY - 1999

Y1 - 1999

N2 - Dental implants may maintain residual alveolar ridge, avoid preparation of the healthy tooth, and provide better retention, support, and chewing functions. However, in the maxillary posterior areas the size and extension of the sinus cavities often jeopardized implantation of dental implants. The mechanisms involved in sinus augmentation and osseointegration are still not fully understood. The amount of new bone regenerated may not be adequate and the time for bone healing may take years to complete; therefore, the success rate of osseointegration in augmented sinus may be lower. Two critical processes for the enhancement of bone healing are to increase the number of local osteoprogenitor cells and to accelerate the rate of bone remodeling. TGF-β may directly or indirectly regulate cells of the bone marrow and re-establish the osteoblast phenotype and enhance new bone formation. During skeletal remodeling, bone grafting materials may also be used to induce or conduct new bone formation. The purpose of this investigation was to evaluate the potential use of TGF-β and / or bone grafting materials on sinus augmentation in vivo. Two, four and six months after sinus elevation and TGF-β and bone graft implantation, dogs were sacrificed. Results were assessed using clinical, histologic, and radiograghic techniques. SEM examination was also performed to evaluate the level of osseointegration ultrastructurally. Computed tomography (CT) showed an increase in mineralization over time for all study groups. CT showed that sinuses grafted with TGE-β /OsteoGen or autogenous bone/OsteoGen exhibited greater bone density than sites grafted with OsteoGen only. Histological results of the present study indicated that TGF-β/OsteoGen, autogenous bone/OsteoGen, and OsteoGen promoted similar amount of new blood vessels and new bone in grafted maxillary sinus. It appeared that TGF-β/OsteoGen formed more new bone marrow. New bone was formed primarily around OsteoGen. While OsteoGen was resorbed, there were still tremendous amounts of residual OsteoGen particles after 6 months of grafting. More new bone marrows were formed as graft time increased.

AB - Dental implants may maintain residual alveolar ridge, avoid preparation of the healthy tooth, and provide better retention, support, and chewing functions. However, in the maxillary posterior areas the size and extension of the sinus cavities often jeopardized implantation of dental implants. The mechanisms involved in sinus augmentation and osseointegration are still not fully understood. The amount of new bone regenerated may not be adequate and the time for bone healing may take years to complete; therefore, the success rate of osseointegration in augmented sinus may be lower. Two critical processes for the enhancement of bone healing are to increase the number of local osteoprogenitor cells and to accelerate the rate of bone remodeling. TGF-β may directly or indirectly regulate cells of the bone marrow and re-establish the osteoblast phenotype and enhance new bone formation. During skeletal remodeling, bone grafting materials may also be used to induce or conduct new bone formation. The purpose of this investigation was to evaluate the potential use of TGF-β and / or bone grafting materials on sinus augmentation in vivo. Two, four and six months after sinus elevation and TGF-β and bone graft implantation, dogs were sacrificed. Results were assessed using clinical, histologic, and radiograghic techniques. SEM examination was also performed to evaluate the level of osseointegration ultrastructurally. Computed tomography (CT) showed an increase in mineralization over time for all study groups. CT showed that sinuses grafted with TGE-β /OsteoGen or autogenous bone/OsteoGen exhibited greater bone density than sites grafted with OsteoGen only. Histological results of the present study indicated that TGF-β/OsteoGen, autogenous bone/OsteoGen, and OsteoGen promoted similar amount of new blood vessels and new bone in grafted maxillary sinus. It appeared that TGF-β/OsteoGen formed more new bone marrow. New bone was formed primarily around OsteoGen. While OsteoGen was resorbed, there were still tremendous amounts of residual OsteoGen particles after 6 months of grafting. More new bone marrows were formed as graft time increased.

KW - TGF-β

KW - sinus augmentation

KW - bone grafting material

KW - osteoinduction

KW - osteoconduction.

M3 - Article

VL - 10

SP - 79

EP - 92

JO - 中華民國口腔顎面外科學會雜誌

JF - 中華民國口腔顎面外科學會雜誌

IS - 2

ER -